S&P ASX All Technology

US Dollar vs AUD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Regeneron Pharmaceuticals Inc (REGN) Share Price

REGN Regeneron Pharmaceuticals Inc

912.79

5.47 (0.60%)

Last Updated: 23:53:30

Delayed by 15 minutes

Period:

Draw Mode:

Volume

34,922

Bid Price	911.51	View Full Level 2
Ask Price	913.90	View Full Level 2

News

Day High

912.865

Low
684.805

52 Week Range

High
998.325

Day Low

904.41

Share Name	Share Symbol	Market	Stock Type
Regeneron Pharmaceuticals Inc	REGN	NASDAQ	Common Stock

	Price Change	Price Change %	Share Price	Last Trade
	5.47	0.60%	912.79	23:53:30

Open Price	Low Price	High Price	Close Price	Previous Close
906.90	904.41	912.865		907.32

Trades	Shares Traded	VWAP	Financial Volume	Average Volume	52 Week Range
1,428	34,922	US$ 907.28	US$ 31,684,011	-	684.805 - 998.325

Last Trade	Type	Quantity	Price	Currency
23:53:38		1	US$ 912.92	USD

Overall Flow

Bearish

Net Premium

-4M

Calls / Puts

100.00%

Buys / Sells

100.00%

OTM / ITM

366.67%

Sweeps Ratio

0.00%

View REGN Options Flow >>

Regeneron Pharmaceuticals Inc Financials

Market Cap	Shares in Issue	Float	Revenue	Profit/Loss	EPS	PE Ratio
99.59B	109.76M	-	13.12B	3.95B	36.02	25.19

Short Interest	Dividends Per Share	Dividend Yield	Ex-Div Date	Insider B/S	Insider % Owned
-		-		-	-

more financials information »

Regeneron Pharmaceuticals News

Date	Time	Source	News Article
25/4/2024	00:05	GlobeNewswire Inc.	Regeneron to Showcase Progress in Advancing Novel..
23/4/2024	07:54	GlobeNewswire Inc.	Regeneron to Highlight Advances in Genetic Medicine Research..
16/4/2024	21:18	IH Market News	Ericsson Soars with 66% Net Profit Growth; Live Nation Under..
11/4/2024	21:24	IH Market News	Costco Increases Dividend by 14%, Meta Introduces ‘Artemis’..
08/4/2024	06:00	GlobeNewswire Inc.	Linvoseltamab Pivotal Data Presented at AACR Reinforce High..
02/4/2024	07:05	GlobeNewswire Inc.	Regeneron to Report First Quarter 2024 Financial and..
25/3/2024	22:00	GlobeNewswire Inc.	Regeneron Provides Update on Biologics License Application..
13/3/2024	14:55	PR Newswire (US)	High School Seniors Win $1.8 Million at Regeneron Science..
13/3/2024	12:30	GlobeNewswire Inc.	High School Seniors Win $1.8 Million at Regeneron Science..
11/3/2024	22:00	GlobeNewswire Inc.	Praluent® (alirocumab) Injection Receives FDA Approval to..
08/3/2024	23:00	GlobeNewswire Inc.	EYLEA® HD (aflibercept) Injection 8 mg Pivotal Data in Wet..
06/3/2024	08:01	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of..

Historical REGN Price Data

Period †	Open	High	Low	VWAP	Avg. Daily Vol	Change	%
1 Week	893.85	920.73	891.46	899.43	423,849	18.94	2.12%
1 Month	971.04	976.75	890.43	923.70	445,386	-58.25	-6.00%
3 Months	961.05	998.325	890.43	948.95	467,162	-48.26	-5.02%
6 Months	796.50	998.325	769.19	896.53	515,444	116.29	14.60%
1 Year	800.43	998.325	684.805	831.37	531,052	112.36	14.04%
3 Years	489.84	998.325	478.40	699.02	649,726	422.95	86.34%
5 Years	344.43	998.325	271.37	582.64	772,129	568.36	165.01%

Regeneron Pharmaceuticals

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions